You are here: Home » PTI Stories » National » News
Business Standard

Strides Shasun gets USFDA nod for Oseltamivir Phosphate capsules

Press Trust of India  |  New Delhi 

Drug firm today said its subsidiary has received final approval from the (USFDA) for generic Phosphate capsules.

The company has received approval from the US health regulator for the capsules in the strengths of 30 mg (base), 45 mg (base) and 75 mg (base), said in a BSE filing.

The product is a generic version of Hoffmann-La Roche Inc's Tamiflu capsules, it added.

"As per IQVIA MAT April 2018 data, the US market for Phosphate Capsules was approximately USD 725 million," said.

The product will be manufactured at the company's oral dosage facility at Bengaluru and will be marketed by in the US market, it added.

Phosphate capsule is prescribed to treat symptoms caused by the

Shares of Strides Shasun today closed at Rs 349.65 apiece on BSE, down 2.25 per cent from its previous close.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Mon, June 11 2018. 20:50 IST